Novartis formed Dec. 20 following FTC approval of Sandoz/Ciba merger.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS AG ESTABLISHED DEC. 20 FOLLOWING FTC PROVISIONAL APPROVAL of the merger between Sandoz and Ciba-Geigy, the companies announced. The two firms reported their intention to merge on March 7 ("The Tan Sheet" March 11, p. 1). Novartis shares will begin trading on the Swiss stock exchange Dec. 23. The Federal Trade Commission's Dec. 17 provisional approval of the merger came nearly six months after the European Commission signed off on the agreement ("The Tan Sheet" July 22, In Brief).